MDSL
MET icon

M.D. Sass LLC’s MetLife MET Stock Holding History

M.D. Sass LLC’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-23,200
Closed -$1.18M – 42
2019
Q4 		$1.18M Sell
23,200
-3,600
-13% -$174K 0.28% 35
2019
Q3 		$1.26M Sell
26,800
-13,300
-33% -$634K 0.3% 36
2019
Q2 		$1.99M Sell
40,100
-8,200
-17% -$385K 0.46% 35
2019
Q1 		$2.06M Sell
48,300
-370,164
-88% -$16.4M 0.33% 36
2018
Q4 		$17.2M Sell
418,464
-71,690
-15% -$3.08M 2.92% 19
2018
Q3 		$22.9M Buy
490,154
+8,114
+2% +$371K 3.02% 18
2018
Q2 		$21M Sell
482,040
-58,896
-11% -$2.75M 2.65% 21
2018
Q1 		$24.8M Buy
540,936
+48,405
+10% +$2.35M 2.89% 16
2017
Q4 		$24.9M Sell
492,531
-47,530
-9% -$2.5M 2.23% 19
2017
Q3 		$28.1M Sell
540,061
-495,608
-48% -$24.1M 2.35% 17
2017
Q2 		$50.7M Sell
1,035,669
-176,315
-15% -$8.18M 3.32% 13
2017
Q1 		$57.1M Buy
1,211,984
+22,120
+2% +$1.05M 2.97% 16
2016
Q4 		$57.2M Sell
1,189,864
-9,330
-0.8% -$428K 3.22% 13
2016
Q3 		$47.5M Sell
1,199,194
-107,992
-8% -$4.06M 2.68% 21
2016
Q2 		$46.4M Sell
1,307,186
-44,538
-3% -$1.74M 2.27% 24
2016
Q1 		$52.9M Buy
1,351,724
+194,198
+17% +$7.26M 2.84% 21
2015
Q4 		$49.7M Buy
1,157,526
+211,056
+22% +$9.28M 2.72% 21
2015
Q3 		$39.8M Buy
946,470
+3,974
+0.4% +$186K 2.19% 23
2015
Q2 		$47M Buy
942,496
+8,179
+0.9% +$387K 2.34% 21
2015
Q1 		$42.1M Buy
934,317
+260,183
+39% +$11.7M 2.14% 23
2014
Q4 		$32.5M Buy
674,134
+22,457
+3% +$1.07M 2.01% 25
2014
Q3 		$31.2M Sell
651,677
-406,131
-38% -$19.7M 1.81% 31
2014
Q2 		$52.4M Sell
1,057,808
-151,353
-13% -$7.08M 3.11% 18
2014
Q1 		$56.9M Buy
1,209,161
+297,015
+33% +$13.7M 3.67% 11
2013
Q4 		$43.8M Sell
912,146
-15,337
-2% -$688K 3.11% 18
2013
Q3 		$38.8M Sell
927,483
-53,456
-5% -$2.3M 3.06% 19
2013
Q2 		$40M Buy
+980,939
New +$36.1M 3.29% 10

Other funds holding MET

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

M.D. Sass LLC's MET Position: Q1 2020 in Review

M.D. Sass LLC sold out of MetLife (MET) in Q1 2020, closing a stake of 23,200 shares — an estimated $1.18M sold.

M.D. Sass LLC first reported a position in MET in Q2 2013 and held it in 27 quarters. The position peaked at $57.2M in Q4 2016. 962 funds tracked by Wall St. Rank hold MET as of Q1 2020.

  • M.D. Sass LLC reported no remaining MetLife position as of Q1 2020 after selling out during the quarter.
  • M.D. Sass LLC sold 23,200 MetLife shares in Q1 2020, an estimated $1.18M.
  • M.D. Sass LLC first reported a position in MetLife in Q2 2013 and held it in 27 quarters.
  • M.D. Sass LLC's MetLife position peaked at $57.2M in Q4 2016.
  • 962 funds tracked by Wall St. Rank held MetLife as of Q1 2020.

Based on M.D. Sass LLC's 13F filing for Q1 2020, filed 6 May 2020.